VistaGen Therapeutics (VTGN)

• Market cap: $23.6M
• 1 day: 1.76%
• 5 days: 6.16%
• 1 month: 2.9%
• 3 months: -83.44%
• 6 months: -83.06%
• Year to date: -12.18%
• 1 year: -76.05%
• 5 years: -99.17%
• 10 years: -99.52%
• Sector: Healthcare
• Industry: Biotechnology

About: Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.

Employees: 59